Email Facebook Twitter

London South East Natural Resources Webcast

Member Info for bigbob0228

Send a private message to bigbob0228

Member Since: Mon, 7th Apr 2008

Number of Share Chat Posts (all time): 135
Number of Share Chat Posts (last 30 days): 0

Last Posted: 16 Jan '18

22 Jun '11

Think this should start testing the 141pps highs of last year very soon, and about time too.
10 May '11

Last February, Sativex® was awarded national reimbursement status in Spain and was launched shortly thereafter. Its initial sales performance in the brief period since launch are aligned with expectations and we are encouraged by the response from physicians to the introduction of this important new medicine to address the needs of people with MS suffering from spasticity
6 May '11

The reason why its rising is that it has been strongly.recommended by a reputable tipster. I bought some this morning for pension. Huge upside.
6 May '11

Anyone got any news of why so many buys this morning.
22 Mar '11

Brokers are fully aware there are many private investors holding shares from 30pps right up to 130pps, I think there game is to frustrate share holders into selling there holdings by keeping the share price low this is IMHO a great time to top up sit back and wait.

16 Dec '10

If Mr Guy delivers us a 300pps price by this time next year I will be more than happy for him to sell all his shares
8 Dec '10


Porton Down, UK, 8 December 2010: GW Pharmaceuticals (AIM: GWP) hereby provides notification that the Company has today been notified of the following share transactions entered into today by Mr Thomas Lynch, a non-executive Director and Dr Geoffrey Guy, a Director and Executive Chairman of the Company.

Mr Thomas Lynch purchased 47,665 ordinary shares of 0.1p each from Dr Geoffrey Guy. This transaction between Directors, which equates to 0.04% of the issued ordinary share capital of the company, took place at the prevailing market price of 104.9 pence per share.

Dr Guy has also today transferred 4,256 ordinary shares of 0.1p each, equating to less than 0.01% of the issued ordinary share capital of the company, into his personal pension scheme. This transaction took place at the prevailing market price of 106.75 pence per share.

Following this notification:

Mr Lynch's holding in the shares of GW Pharmaceuticals PLC is 47,665 ordinary shares, amounting to 0.04% of shares in issue.

Dr Guy retains a beneficial interest in 18,306,783 ordinary shares, amounting to 13.95% of the shares in issue.

The total number of shares outstanding in the Company is 131,243,292 ordinary shares of 0.1p each.

For further information, please contact:

GW Pharmaceuticals PLC +44 (0)1980 557 000

Adam George, Company Secretary

Peel Hunt Ltd (Nominated Adviser)

James Steel/Vijay Barathan +44 (0) 207 418 8900

Sign up for Live Prices
Top Recommended
Hot Chat Topics
Top recommended posters in the last 30 days

Member Login

Forgotten your password?


Don't have an account? Click here to Register Free!

Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.